Early research (Phase 1)Study completedNCT02287558
What this trial is testing
Pomalidomide in Hereditary Hemorrhagic Telangiectasia and Transfusion-Dependent Vascular Ectasia: a Phase I Study
Who this might be right for
Hereditary Hemorrhagic TelangiectasiaIdiopathic Vascular Ectasia
The Cleveland Clinic 9